Effectiveness and Safety of the TRIO Optimal Health Management Program in Patients With Type 2 Diabetes Mellitus Initiating Basal Insulin Therapy: Prospective Observational Real-World Study

Chenxi Li   ¹ , Dr med ;   Lixin Guo   ² , MEd ;   Lixin Shi   ³ , MEd ;   Li Chen   ⁴ , MEd ;   Liming Chen   ⁵ , MEd ;   Yaoming Xue   ⁶ , MEd ;   Hong Li   ⁷ , MEd ;   Yuzhen Liang   ⁸ , MEd ;   Jing Yang   ⁹ , MEd ;   Weimin Wang   ^{1 *} , MEd ;   Dalong Zhu   ^{1 *} , MEd

¹ Department of Endocrinology, Endocrine and Metabolic Disease Medical Center, Nanjing Drum Tower Hospital, Affiliated Hospital of Nanjing Medical School, Nanjing, China

² Department of Endocrinology, Peking Union Medical College, Chinese Academy of Nanjing Medical Sciences, Beijing, China

³ Department of Endocrinology, Affiliated Hospital of Guiyang Medical University, Guiyang, China

⁴ Department of Endocrinology, Qilu Hospital of Shandong University, Jinan, China

⁵ NHC Key Laboratory of Hormones and Development, Tianjin Key Laboratory of Metabolic Diseases, Chu Hsien-I Memorial Hospital & Tianjin Institute of Endocrinology, Tianjin Medical University, Tianjin, China

⁶ Department of Endocrinology & Metabolism, Nanfang Hospital, Southern Medical University, Guangzhou, China

⁷ Department of Endocrinology and Metabolism, The First Affiliated Hospital of Kunming Medical University, Kunming, China

⁸ Department of Endocrinology, The Second Affiliated Hospital of Guangxi Medical University, Nanjing, China

⁹ Department of Endocrinology, First Hospital of Shanxi Medical University, Taiyuan, China

*these authors contributed equally